Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample, 783-784 [2012-18]

Download as PDF pmangrum on DSK3VPTVN1PROD with NOTICES Federal Register / Vol. 77, No. 4 / Friday, January 6, 2012 / Notices consultants, with special expertise, to assist the Board on an ad hoc basis. These experts and consultants, appointed under the authority of 5 U.S.C. 3109, shall serve as special government employees; however, they shall have no voting rights on the Board. Non-voting ex-officio members, nonvoting senior fellows, non-voting observers and those non-voting experts and consultants appointed by the Secretary of Defense shall not count toward the Board’s total membership. The Department, when necessary, and consistent with the Board’s mission and DoD policies and procedures may establish subcommittees, task groups, or working groups deemed necessary to support the Board. These subcommittees or working groups shall operate under the provisions of the FACA, the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), other governing Federal statutes and regulations, and governing DoD policies and procedures. Such subcommittees or task groups shall not work independently of the chartered Board, and shall report all their recommendations and advice to the Board for full deliberation and discussion. Subcommittees have no authority to make decisions on behalf of the chartered Board; nor can any subcommittee or its members update or report directly to the Department of Defense or any Federal officers or employees. All subcommittee members shall be appointed in the same manner as the Board members; that is, the Secretary of Defense shall appoint subcommittee members even if the member in question is already a Board member. Subcommittee members, with the approval of the Secretary of Defense, may serve a term of service on the subcommittee of one to four years; however, no member shall serve more than two consecutive terms of service on the subcommittee. Subcommittee members, if not full-time or part-time government employees, shall be appointed to serve as experts and consultants under the authority of 5 U.S.C. 3109, and to serve as special government employees, whose appointments must be renewed on an annual basis. With the exception of travel and per diem for official travel, subcommittee members shall serve without compensation. Jim Freeman, Acting Advisory Committee Management Officer for the Department of Defense, (703) 692–5952. FOR FURTHER INFORMATION CONTACT: VerDate Mar<15>2010 14:40 Jan 05, 2012 Jkt 226001 The Board shall meet at the call of the Board’s Designated Federal Officer, in consultation with the Chairperson. The estimated number of Board meetings is four per year. The Board’s Designated Federal Officer, pursuant to DoD policy, shall be a full-time or permanent part-time DoD employee, and shall be appointed in accordance with governing DoD policies and procedures. The Board’s Designated Federal Officer is required to be in attendance at all Board and subcommittee meetings for the entire duration of each and every meeting. However, in the absence of the Board’s Designated Federal Officer, an Alternate Designated Federal Officer, duly appointed to the Board according to DoD policies and procedures, shall attend the entire duration of the Board or subcommittee meetings. The Designated Federal Officer, or the Alternate Designated Federal Officer, shall call all of the Board’s and subcommittee’s meetings, prepare and approve all meeting agendas, and adjourn any meeting, when the Designated Federal Officer, or the Alternated Designated Federal Officer, determines adjournment to be in the public’s interest or required by governing regulations or DoD policies/ procedures. Pursuant to 41 CFR 102–3.105(j) and 102–3.140, the public or interested organizations may submit written statements to the Defense Business Board’s membership about the Board’s mission and functions. Written statements may be submitted at any time or in response to the stated agenda of planned meeting of Defense Business Board. All written statements shall be submitted to the Designated Federal Officer for the Defense Business Board, and this individual will ensure that the written statements are provided to the membership for their consideration. Contact information for the Defense Business Board Designated Federal Officer can be obtained from the GSA’s FACA Database—https://www.fido.gov/ facadatabase/public.asp. The Designated Federal Officer, pursuant to 41 CFR 102–3.150, will announce planned meetings of the Defense Business Board. The Designated Federal Officer, at that time, may provide additional guidance on the submission of written statements that are in response to the stated agenda for the planned meeting in question. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00009 Fmt 4703 Sfmt 4703 783 Dated: January 3, 2012. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2012–58 Filed 1–5–12; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning a Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample AGENCY: ACTION: Department of the Army, DoD. Notice. The invention provides a method for the controlled delivery of a drug as a function of bioavailable drug concentration, a sensor device for detecting bioavailable drug concentration, and a delivery device that controls delivery of the drug based on the real-time detection of bioavailable drug concentration. Announcement is made of the availability for licensing of the invention set forth in International Patent Application No. PCT/US2009/ 060852 entitled, ‘‘Method and Device for Detection of Bioavailable Drug Concentration in a Fluid Sample,’’ filed on October 15, 2009 (which claims the benefit of U.S. Provisional Patent Application Serial No. 651/105,604 filed October 15, 2008). The United States Government, as represented by the Secretary of the Army, has rights to this invention. U.S. and selected foreign rights are available. SUMMARY: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. ADDRESSES: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. FOR FURTHER INFORMATION CONTACT: The invention relates to the method of electrochemical detection of bioavailable drug concentration intended to be used to modify the SUPPLEMENTARY INFORMATION: E:\FR\FM\06JAN1.SGM 06JAN1 784 Federal Register / Vol. 77, No. 4 / Friday, January 6, 2012 / Notices delivery rate of the drug to a patient during real-time. DEPARTMENT OF EDUCATION Notice of Submission for OMB Review Brenda S. Bowen, Army Federal Register Liaison Officer. Correction [FR Doc. 2012–18 Filed 1–5–12; 8:45 am] BILLING CODE 3710–08–P DEPARTMENT OF DEFENSE Department of the Army Notice of Availability for Exclusive, Non-Exclusive, or Partially-Exclusive Licensing of an Invention Concerning Extraction and Detection of Pathogens Using Carbohydrate-Functionalized Biosensors In notice document 2011–33263 appearing on pages 81486–81487 in the issue of Wednesday, December 28, 2011, make the following correction: On page 81486, in the second column, under the DATES heading, in the third line ‘‘December 28, 2011’’ should read ‘‘January 27, 2012’’. [FR Doc. C1–2011–33263 Filed 1–5–12; 8:45 am] BILLING CODE 1505–01–P DEPARTMENT OF EDUCATION Department of the Army, DoD. ACTION: Notice. Statewide Longitudinal Data Systems; Reopening Fiscal Year (FY) 2012 Competition The invention provides extraction and detection of pathogens using carbohydrate-functionalized biosensors. Specific analyte can be achieved with an analyte probe having a detection moiety and a binding pair member specific to the target analyte of interest. Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application No. 61/528,892, entitled ‘‘Extraction and Detection of Pathogens Using CarbohydrateFunctionalized Biosensors,’’ filed on August 30, 2011. The United States Government, as represented by the Secretary of the Army, has rights to this invention. U.S. and selected foreign rights are available. ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR–JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702– 5012. AGENCY: AGENCY: SUMMARY: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619–7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619–6664, both at telefax (301) 619–5034. SUPPLEMENTARY INFORMATION: The invention relates to a method for detecting the presence of a target analyte, a kit for binding a target analyte and a target analyte complex. Various refinements and extensions of the foregoing methods, kits and target analyte complex are possible. pmangrum on DSK3VPTVN1PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Brenda S. Bowen, Army Federal Register Liaison Officer. [FR Doc. 2012–21 Filed 1–5–12; 8:45 am] BILLING CODE 3710–08–P VerDate Mar<15>2010 14:40 Jan 05, 2012 Jkt 226001 Institute of Education Sciences (IES), Department of Education. ACTION: Notice reopening the Statewide Longitudinal Data Systems fiscal year (FY) 2012 competition. Catalog of Federal Domestic Assistance (CFDA) Number: 84.372A On September 20, 2011, we published in the Federal Register (76 FR 58252) a notice inviting applications for the Statewide Longitudinal Data Systems FY 2012 competition. That notice established a December 15, 2012, deadline date for eligible applicants to apply for funding under this program. As a result of the notice published on September 20, 2011, 31 eligible entities submitted applications. In order to ensure fairness and afford as many eligible applicants as possible an opportunity to be considered for funding under this program, we are reopening the Statewide Longitudinal Data Systems FY 2012 competition to eligible applicants that were not able to submit applications by the original deadline date. Thus, we will consider as received timely, all of the applications we received through Grants.gov by December 15, 2011 (referred to as ‘‘previously submitted applications’’ in this notice), and will consider as timely any additional applications or revisions to any previously submitted application submitted by the new deadline date established in this notice. All information in the September 20, 2011 notice remains the same for new applications and revisions to previously submitted applications submitted in response to this reopening notice, except for the following updates to the Dates section and section V. Submission of Applications. SUMMARY: PO 00000 Frm 00010 Fmt 4703 Sfmt 4703 Applications Available: January 6, 2012. DATES: Note: The application package for this competition and instructions are available at the following Internet address: https://ies.ed. gov/funding/slds.asp Deadline for Transmittal of Applications: January 13, 2012. V. Submission of New Applications or Revisions to Previously Submitted Applications New applications or revisions to previously submitted applications for grants under this program must be submitted in paper format by mail or hand delivery. a. Submission of Paper Applications by Mail If you submit your new application or revisions to a previously submitted application by mail (through the U.S. Postal Service or a commercial carrier), you must mail the original and two copies of your new application or revisions to a previously submitted application, on or before the application deadline date, to the Department at the following address: U.S. Department of Education, Application Control Center, Attention: (CFDA Number: 84.372A), LBJ Basement Level 1, 400 Maryland Avenue SW., Washington, DC 20202– 4260. You must show proof of mailing consisting of one of the following: (1) A legibly dated U.S. Postal Service postmark. (2) A legible mail receipt with the date of mailing stamped by the U.S. Postal Service. (3) A dated shipping label, invoice, or receipt from a commercial carrier. (4) Any other proof of mailing acceptable to the Secretary of the U.S. Department of Education. If you mail your new application or revisions to a previously submitted application through the U.S. Postal Service, we do not accept either of the following as proof of mailing: (1) A private metered postmark. (2) A mail receipt that is not dated by the U.S. Postal Service. If your new application or revisions to a previously submitted application is postmarked after the application deadline date, we will not consider your new application or revisions to a previously submitted application. Note: The U.S. Postal Service does not uniformly provide a dated postmark. Before relying on this method, you should check with your local post office. E:\FR\FM\06JAN1.SGM 06JAN1

Agencies

[Federal Register Volume 77, Number 4 (Friday, January 6, 2012)]
[Notices]
[Pages 783-784]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-18]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Notice of Availability for Exclusive, Non-Exclusive, or 
Partially-Exclusive Licensing of an Invention Concerning a Method and 
Device for Detection of Bioavailable Drug Concentration in a Fluid 
Sample

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The invention provides a method for the controlled delivery of 
a drug as a function of bioavailable drug concentration, a sensor 
device for detecting bioavailable drug concentration, and a delivery 
device that controls delivery of the drug based on the real-time 
detection of bioavailable drug concentration. Announcement is made of 
the availability for licensing of the invention set forth in 
International Patent Application No. PCT/US2009/060852 entitled, 
``Method and Device for Detection of Bioavailable Drug Concentration in 
a Fluid Sample,'' filed on October 15, 2009 (which claims the benefit 
of U.S. Provisional Patent Application Serial No. 651/105,604 filed 
October 15, 2008). The United States Government, as represented by the 
Secretary of the Army, has rights to this invention. U.S. and selected 
foreign rights are available.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Applications (ORTA), (301) 619-
6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates to the method of 
electrochemical detection of bioavailable drug concentration intended 
to be used to modify the

[[Page 784]]

delivery rate of the drug to a patient during real-time.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2012-18 Filed 1-5-12; 8:45 am]
BILLING CODE 3710-08-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.